[VYNE] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
04-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 6.20%
YoY- -7.83%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 4,086 4,258 4,119 4,286 3,269 11,688 1,750 75.90%
PBT -21,285 -19,924 -20,550 -23,181 -24,713 -167,699 -40,233 -34.56%
Tax 3,439 1,005 1,005 -258 1 -259 728 181.27%
NP -21,285 -19,924 -20,550 -23,181 -24,714 -167,440 -40,233 -34.56%
Tax Rate - - - - - - - -
Total Cost 25,371 24,182 24,669 27,467 27,983 179,128 41,983 -28.49%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -520.93 -467.92 -498.91 -540.85 -756.01 -1,432.58 -2,299.03 -62.79%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -7.36 -6.98 -7.57 -8.54 -10.61 -86.95 -68.15 -77.29%
EPS Diluted -7.36 -6.98 -7.57 -8.54 -10.61 -86.95 -68.15 -77.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.